NMM.DENMM.DEXETRA
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+78.9%
5Y CAGR+18.6%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+78.9%/yr
vs -1.7%/yr prior
5Y CAGR
+18.6%/yr
Recent acceleration
Acceleration
+80.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$13.51B+79.4%
2024$7.53B+2252.5%
2023$320.00M-86.4%
2022$2.36B-36.3%
2021$3.71B-35.6%
2020$5.75B-3.4%
2019$5.95B+135.4%
2018$2.53B-1.7%
2017$2.57B+103.3%
2016$1.27B-